AI assistant
Sending…
MACROGENICS INC — Director's Dealing 2017
Sep 7, 2017
34129_dirs_2017-09-07_47938778-f302-4506-a25d-9eb65fca1cd8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2017-09-05
Reporting Person: Risser Eric Blasius (Sr VP & Chief Business Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-09-05 | Common Stock | M | 2000 | $0.94 | Acquired | 6000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-09-05 | Employee stock option (right to buy) | $0.94 | M | 2000 | Disposed | 2019-03-23 | Common Stock (2000.0) | Direct |
Footnotes
F1: The total reported in Column 9 has been adjusted to correct a prior calculation error in the Form 4 filed by the reporting person on February 8, 2016, which understated the total number of shares.
More from MACROGENICS INC
Declaration of Voting Results & Voting Rights Announcements
2026
May 20
Regulatory Filings
2026
May 13
Merger & Acquisition
2026
May 12
Proxy Solicitation & Information Statement
2026
Apr 8
Major Shareholding Notification
2026
Mar 27
Board/Management Information
2026
Mar 2
Regulatory Filings
2026
Feb 24
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18